Brain Age Gap: A Key Biomarker ‍Linking lifestyle Risks to Cognitive⁤ Decline in Southeast Asia

Singapore ⁢- ⁣New research from Singapore suggests that the “brain age gap” – the difference between a person’s chronological age adn their brain’s estimated ‌age – may act as ‍a crucial intermediate biomarker, connecting modifiable lifestyle risk factors to cognitive ‌decline, particularly in individuals with cerebrovascular disease (CeVD). The ‌study, published in a ⁤leading medical journal,⁢ highlights‍ the importance of considering‍ vascular burden and domain-specific‍ cognitive outcomes in understanding brain aging, especially⁤ within Asian populations.

bridging the Gap in Cognitive ​Research

Prior research on cognitive decline has predominantly focused on Western populations, leaving a significant ⁢gap in understanding how conditions⁢ like cerebrovascular disease (CeVD), ⁢which is highly prevalent in Asia, might interact with brain age gap (BAG) to affect cognition.Dr. Hilal,⁤ the lead researcher, emphasized this point, noting that CeVD frequently enough coexists with Alzheimer’s pathology in individuals from Southeast Asia. Understanding ​whether BAG‌ could mediate this relationship “could enhance early‍ risk stratification and open new avenues for targeted​ cognitive interventions ​in at-risk populations,” she stated.

methodology: Unpacking Cognitive risk Factors

The researchers conducted a ‍extensive review of‍ medical records for over ⁢2000 participants from Singaporean community and memory clinics.The average age of participants was ‍66 years, with 53% being men. A significant⁤ portion, 60%, had ‌no cognitive impairment at the time of the study.To identify cognitive impairment risk factors,the team utilized the Cognitive Impairment Scoring System (CISS). This system comprises 11 sociodemographic and vascular factors,⁣ including age, education level, ⁣smoking status, blood pressure, and a ‌history of diabetes.Cognitive performance was meticulously assessed using a battery of tests ​designed to evaluate⁤ various cognitive domains. These included overall global cognition, executive⁣ function, language, memory, attention, visuomotor speed (the ability to coordinate visual information with motor actions),⁢ and visuoconstruction (the coordination of fine motor⁢ skills with spatial abilities).The study population consisted of 1437 individuals without dementia and ⁢a matched control group of 646 individuals. All participants had undergone structural magnetic resonance imaging (MRI) scans. CeVD burden was quantified using markers associated ‌with small and large vessel disease and cognitive dysfunction, such as lacunar and cortical infarcts, cerebral microbleeds, and white matter hyperintensities.

Key Findings:⁢ BAG as a Meaningful‌ Biomarker

The ‍results revealed a significant⁤ association between a higher CISS score (indicating a greater number of impairment‌ risk factors) and lower performance across all measured cognitive ‌domains. Visuomotor speed (β = -2.7; P < .001) and visuoconstruction (β = -3.0; P ​ < ⁢.001) where particularly affected. Crucially, the study found that BAG significantly influenced the relationship between CISS score and global cognition in the entire patient population,⁤ with a mediation effect of 9% (P < .05). This influence was even more pronounced in specific cognitive domains, particularly language (18%; P ⁤ = .001) and⁤ visuoconstruction (10%; P = .008).

The impact of BAG was amplified in individuals ‍with a high⁢ CeVD burden. ⁣In this subgroup, the association‌ between CISS score and overall ⁣global cognition was significantly mediated by BAG (20%; P = .01).⁤ Executive function (34%; P = .03) ‌and language abilities ​(27%; P ⁣= .008) also showed significant mediation by BAG in this high-CeVD‌ burden group. Conversely, no significant mediating effects of BAG were observed‍ in the low-CeVD-burden group.

“These findings underscore the importance of stratifying​ by vascular burden and considering domain-specific outcomes ⁤when investigating brain aging,” Dr. Hilal commented. “For clinicians, the key message is that the brain‍ age gap can serve as a meaningful intermediate biomarker linking modifiable risk factors to cognitive decline.”

Future Directions and Limitations

While the study provides‌ valuable insights, the researchers acknowledged that its focus on a Southeast Asian population might limit the generalizability of ⁢the findings to​ other ⁤demographic groups. They recommended future longitudinal studies to validate these relationships and explore additional factors not included in the current model.

The research was supported by funding from the⁣ National University of Singapore, the National ⁢Medical Research Council Singapore, and the Singapore Ministry of Education. The investigators reported no ⁤relevant⁢ financial conflicts of interest.